Experiencing the arrival of a baby can be an extremely stressful and concerning time for any parent.
However, parents of children diagnosed with spinal muscular atrophy (SMA) often share similar distressing narratives. These parents not only face the shock of a belated diagnosis due to NHS shortcomings but also grapple with overwhelming guilt.
Initially, parents leave the hospital with apparently healthy babies, only to notice worrisome signs as time passes. Their babies’ movements decrease, breathing becomes laborious, and feeding poses increasing challenges.
Despite repeatedly expressing concerns to healthcare professionals, including doctors and nurses, parents are reassured that everything is fine. Babies continue to lose weight, requiring readmission to hospitals, sometimes even to intensive care following common infections.
Regrettably, the NHS often overlooks key indicators such as lack of movement and breathing difficulties, despite parents’ persistent observations.
In many instances, it is the parents who, after researching symptoms online, self-diagnose their child with SMA. Subsequently, panicked parents inform healthcare providers of the diagnosis, leading to confirmation through a simple blood test, often too late to prevent irreversible damage.
Parents receive confirmation that their baby carries an inherited genetic defect in the SMN1 gene, responsible for producing a protein vital for nerve cell health. Without this protein, motor neurons perish, causing muscle atrophy.
Immediate administration of one of three available transformative treatments on the NHS either corrects the defective gene or supplies a substitute protein to halt further muscle degeneration, ultimately saving the child’s life.
Despite the life-saving treatments, parents are left with the haunting realization that timely intervention could have offered their child a relatively normal life, free from severe disabilities.
No parent should bear the burden of knowing they did everything possible to voice concerns, only to be dismissed by an NHS seemingly unaware of this condition.
Since 2021, I have been hearing from these resilient parents narrating their experiences. The profound injustice of mourning an unexpected life course while shouldering self-blame for their child’s forthcoming challenges is striking.
As long as the UK neglects universal screening for SMA in newborns, the double injustice faced by parents will cast a shadow on NHS maternity care.
The tight-knit SMA community demonstrates exceptional support and camaraderie, having weathered an ordeal that remains incomprehensible to those who have not endured it.
Amidst the darkness, these parents find glimmers of hope, witnessing their once-ailing children attending school, fostering friendships, and exuding joy. These children exhibit cognitive sharpness akin to their peers.
Although the future remains uncertain due to the novelty of their treatments, these children represent the inaugural SMA generation with a chance at surviving beyond childhood.
In the future, many of these children will emerge as vocal adults, shedding light on the protracted delay in SMA screening, potentially exposing it as a national scandal. The lack of widespread awareness is largely due to SMA’s rarity.
Celebrity Jesy Nelson, who has children with SMA, courageously highlighted the repercussions of delayed diagnoses, compelling authorities to take notice.
Health Secretary Wes Streeting is now pressuring the UK National Screening Committee, which has procrastinated on SMA screening implementation for too long.
Incorporating SMA checks into the NHS heel prick test upon birth, as practiced in most developed countries, is imperative to early detection.
Ultimately, credit is due to the relentless advocacy of SMA parents, striving to spare others from the same dual injustice they endured.